Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Waterdrop Inc. Announces Third Quarter 2022 Unaudited Financial Results 2022-12-06 16:30
University of Tokyo and Sekisui House Launch Joint Research on Biodiversity and Health 2022-12-06 14:00
SK Biopharmaceuticals Wins Export Award for Cenobamate 2022-12-06 08:00
Meihua International Medical Technologies Co., Ltd. Appoints New CEO, CFO and Directors 2022-12-05 22:33
China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project 2022-12-05 21:00
Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform 2022-12-05 20:30
Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp 2022-12-05 20:00
The First IBCC Unveiled in Hainan 2022-12-05 15:55
Seoul National University Bundang Hospital Presents Study of SK Biopharmaceuticals' Seizure Detection Wearable Device at AES 2022 2022-12-05 08:00
Qilu Pharmaceutical Releases Latest Results of QL1604 plus Chemotherapy as First-Line Treatment for Patients with Advanced Cervical Cancer in the Phase II Study at ESMO Asia Congress 2022 2022-12-04 17:00
JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential 2022-12-03 09:58
China Pharma Announces Receipt of Noncompliance Notice from NYSE American 2022-12-03 05:10
Lakeshore Acquisition Corp I Shareholders Approve Business Combination with ProSomnus 2022-12-03 05:05
Qilu Pharmaceutical Releases Latest Results of QL1706 plus Chemotherapy +/- Bevacizumab for the Treatment of Non-Small Cell Lung Cancer in the Phase II Study at ESMO Asia Congress 2022 2022-12-02 16:20
Waterdrop Inc. to Report Third Quarter 2022 Financial Results on December 6, 2022 2022-12-02 11:43
Jacobio's Preclinical Results of KRAS G12C Inhibitor in Combination with SHP2 Inhibitor Will be Presented at the ESMO Asia Congress 2022 2022-12-02 08:30
Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826's Treatment of Female Androgenetic Alopecia in China Was Met 2022-12-01 19:30
111, Inc. Announces Third Quarter 2022 Unaudited Financial Results 2022-12-01 15:33
SK Biopharmaceuticals Names Donghoon Lee, Head of Bio Investment Center of SK Inc., as New CEO 2022-12-01 09:30
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio 2022-12-01 08:00
1 114 115 116 117 118 801